Main navigation
Search Results
-
-
Press release - 28/09/2022 First successful trial for early detection of HPV-related cancer of the pharynx
Screening trials for the early detection of rare diseases often fail due to insufficient predictive power of the results. For the rare HPV-related cancer of the pharynx, scientists from the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) now relied on the combined detection of antibodies against two different viral proteins in a proof-of concept trial.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/erste-erfolgreiche-studie-zur-frueherkennung-von-hpv-bedingtem-krebs-im-rachenraum -
Event - MERCK BioLabs Day: Pathway for Pioneers
Heidelberg, Informationsveranstaltunghttps://www.gesundheitsindustrie-bw.de/en/event/merck-biolabs-day-pathway-pioneers -
Press release - 23/09/2022 Phytopharmaceuticals and valuable plant ingredients - opportunities for industry and agriculture in Baden-Württemberg
The "Phytopharmaceuticals and Valuable Plant Ingredients" initiative aims to make the key economic issue of phytopharmaceuticals more visible in Baden-Württemberg in order to gain a better understanding of the challenges and needs of the state’s pharmaceutical industry. The overall goal is to strengthen the use of secondary plant ingredients in valuable products and build on this to develop opportunities for Baden-Württemberg…
https://www.bio-pro.de/en/information/press-release/phytopharmaceuticals-and-valuable-plant-ingredients-opportunities-industry-and-agriculture-baden-wuerttemberg -
Hummingbird Diagnostics GmbH - 22/09/2022 The great potential of blood-based microRNA analyses
"The early bird catches the worm", is an apt description of what motivates Hummingbird Diagnostics GmbH from Heidelberg. The medium-sized biotechnology company analyses special biomarkers in blood, so-called microRNAs, in order to diagnose diseases at an early stage and to be able to make forecasts about the course of the disease and the success of therapy.
https://www.gesundheitsindustrie-bw.de/en/article/news/great-potential-blood-based-microrna-analyses -
Press release - 21/09/2022 ERC funding: How to deliver gene therapies to a specific target site?
With its "Proof of Concept" grants, the European Research Council ERC supports scientists in further developing the commercial potential of their research results. Nina Papavasiliou from the DKFZ is now receiving the prestigious grant for the second time: she wants to advance the development of a "molecular delivery service" that ensures that therapeutic genes reach the right address in the body in a targeted manner.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/erc-funding-how-deliver-gene-therapies-specific-target-site -
Event - - Trinational HealthTech Days 2022
Basel and Online, Informationsveranstaltunghttps://www.gesundheitsindustrie-bw.de/en/event/trinational-healthtech-days-2022 -
Press release - 19/09/2022 How stressed tumor cells escape cell death: new mechanism discovered
Because of their highly active metabolism, many tumors are susceptible to a special type of cell death, ferroptosis. Nevertheless, cancer cells often manage to escape this fate. Scientists at the German Cancer Research Center have now discovered a new mechanism by which normal as well as cancer cells protect themselves against ferroptosis.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/how-stressed-tumor-cells-escape-cell-death-new-mechanism-discovered -
Article - 14/09/2022 Theranostics of prostate cancer: the combination of radionuclide diagnostics and radionuclide therapy
Using a low-level radiopharmaceutical that binds to the prostate-specific membrane antigen (PSMA), positron emission tomography/computed tomography can be used to visualise even small prostate cancer metastases. Developed by Heidelberg researchers, the radiopharmaceutical is a modified radionuclide diagnostic agent that has been coupled with a powerful emitter and used as a therapeutic tracer to irradiate and destroy cancer cells from within.
https://www.gesundheitsindustrie-bw.de/en/article/news/theranostics-prostate-cancer-combination-radionuclide-diagnostics-and-radionuclide-therapy -
Event - - Shift Medical 2022 – Medical XR Congress & Expo
Heidelberg, Kongress/Symposiumhttps://www.gesundheitsindustrie-bw.de/en/event/shift-medical-2022-medical-xr-congress-expo -
Press release - 12/09/2022 Bioeconomy between food and energy crisis - Opinion of the Bioeconomy Council
In its statement of September 2, 2022, the Bioeconomy Council of the German government condemns the Russian war of aggression on Ukraine and points out ways in which the resulting food and energy crisis can be alleviated with the help of the bioeconomy.
https://www.biooekonomie-bw.de/en/articles/pm/biooekonomie-zwischen-ernaehrungs-und-energiekrise-stellungnahme-des-biooekonomierats -
Event - - EKFZ | InnoDays
Dresden, Informationsveranstaltunghttps://www.gesundheitsindustrie-bw.de/en/event/ekfz-innodays -
Event - - MedFIT 2022
Grenoble (Frankreich) and Online, Informationsveranstaltunghttps://www.gesundheitsindustrie-bw.de/en/event/medfit-2022 -
Press release - 09/09/2022 Breaking down proteins: How starving cancer cells switch food sources
Cancer cells often grow in environments that are low in nutrients, and they cope with this challenge by switching their metabolism to using proteins as alternative "food". Building on genetic screens, an international team of scientists could identify the protein LYSET as part of a pathway that allows cancer cells to make this switch. Their findings are now published in the journal Science.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/neu-identifiziertes-protein-ermoeglicht-krebszellen-auf-alternative-nahrungsquellen-auszuweichen -
Event - - MEDICA Healthcare Brokerage Event 2022
Düsseldorf and Online, Registration deadline: Messehttps://www.gesundheitsindustrie-bw.de/en/event/medica-healthcare-brokerage-event-2022 -
Dossier - 08/09/2022 Imaging methods in medical diagnostics
Many different imaging methods are available these days and are used in almost all medical disciplines to visualise disease-related changes. Depending on the problem and the clinical picture, very different structural and functional parameters can be visually recorded for diagnosis and used for therapy.
https://www.gesundheitsindustrie-bw.de/en/article/dossier/imaging-methods-medical-diagnostics -
Press release - 06/09/2022 Biointelligent sensor for measuring viral activity
Today, genome editing is almost as easy as programming software. However, the generation of viral vectors as initial material is still associated with many expensive and error-prone handling procedures. Viruses are generated via complex biological processes that have to be optimised virus-specifically in order to produce high-quality therapeutics. A new method is needed that simplifies and optimises these processes.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/Biointelligent-sensor-for-measuring-viral-activity -
Funding Regulations governing the funding of international collaborative projects under the National Bioeconomy Strategy “Bioeconomy International 2022"
Funding programme, Funded by: BMBF, sb_search.searchresult.label.programSubmissionDate: 14/12/2022https://www.bio-pro.de/en/service/funding/regulations-governing-funding-international-collaborative-projects-under-national-bioeconomy-strategy-bioeconomy-international-2 -
Sustainable nutrition - 05/09/2022 Insect pasta: eating healthily and improving the world at the same time
Insects on the dinner plate? Some people instantly dismiss the idea. Wrongly so, because in terms of animal welfare, ecological footprint and healthy nutrition, insect foods are much better than all other animal foods and are produced in a more controlled way. The fact that they can also taste really good is proven by the start-up Beneto Foods from Albstadt, which has developed protein-rich pasta in various flavours using cricket flour.
https://www.biooekonomie-bw.de/en/articles/news/insect-pasta-eating-healthily-and-improving-world-same-time -
Press release - 01/09/2022 Personalised antibiotic treatment strategies for tuberculosis patients
Tuberculosis is one of the leading causes of death worldwide, with an estimated 1.4 million deaths and ten million people infected annually. Resistant and multidrug-resistant (MDR) variants of the tuberculosis pathogen Mycobacterium tuberculosis pose a major threat to tuberculosis control and global health.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/personalisierte-antibiotika-behandlungsstrategie-bei-tuberkulose-erkrankten -
Press release - 31/08/2022 Using nanopores to detect epigenetic changes faster
Changes known as epigenetic modifications play an important role in cancer development, among other things. Being able to analyze them quickly and reliably could, for example, contribute significantly to the further development of personalized therapy.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/using-nanopores-detect-epigenetic-changes-faster -
Project BW2Pro - 29/08/2022 Biowaste to Products: biorefinery transforms biowaste into new products
In 2020, Germany’s population collected over 5 million tonnes of biowaste. Most of this was composted, and some was fermented into biogas. Scientists in Baden-Württemberg think there's room for more. Within the project ‘Biowaste to Products’ (BW2Pro) they want to transform biowaste into new products in a biorefinery. The idea is to produce biodegradable plant pots, mulch material, fertilisers, enzymes and biobased plastics in addition to…
https://www.biooekonomie-bw.de/en/articles/news/biowaste-products-biorefinery-transforms-biowaste-new-products -
Press release - 18/08/2022 CureVac Starts Phase 1 Clinical Study of Modified, Omicron-Targeting COVID-19 Vaccine Candidate
CureVac N.V., a global biopharmaceutical company developing a new class of transformative medicines based on mRNA, today announced the start of a Phase 1 study of the modified COVID-19 mRNA vaccine candidate CV0501, administered as a booster dose to previous COVID-19 vaccination. Developed in collaboration with GSK, CV0501 is based on CureVac’s second-generation mRNA backbone and is designed to specifically protect against the Omicron variant.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/curevac-starts-phase-1-clinical-study-modified-omicron-targeting-covid-19-vaccine-candidate -
Press release - 18/08/2022 When smooth muscle cells lack strength
University of Tübingen team discovers how malformations of the blood vessels can occur in mice – yielding information with possible ramifications for retinal disease.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/when-smooth-muscle-cells-lack-strength -
Event - IDEA 2022: IgG Drug Delivery via the airways – focus on inhalative and intranasal application
Biberach and Online, Informationsveranstaltunghttps://www.gesundheitsindustrie-bw.de/en/event/idea-2022-igg-drug-delivery-airways-focus-inhalative-and-intranasal-application